Sight Sciences Announces $34M Patent Infringement Verdict Against Alcon And Its Hydrus Microstent For Microinvasive Glaucoma Surgery; Monetary Damages Comprised Of $5.5M In Lost Profits And $28.5M In Royalty Damages For Sales Of The Hydrus Microstent For The Period From Its Commercial Launch Through Trial
Sight Sciences宣布对爱尔康及其Hydrus Microstent进行微创青光眼手术的3400万美元专利侵权判决；金钱赔偿包括550万美元的利润损失和从商业上市到试用期间销售Hydrus Microstent的2850万美元特许权使用费赔偿